POOL vs RNAC · P/E 18, rev $5.31B vs P/E 2.1, rev $38.9M
Pool Corporation (POOL) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
POOL currently screens at market cap $7.08B and trailing P/E 17.9. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the POOL and RNAC stock pages for the full models.
Not investment advice.